
|Articles|April 12, 2019
Future is bright for regenerative ophthalmology
Joel S. Schuman, MD, FACS, shares what's in store for regenerative ophthalmology at the annual Glaucoma 360 2019 meeting.
Advertisement
Joel S. Schuman, MD, FACS, shares the main takeaways from the "New Horizons in Vision Restoration: Innovations in Regenerative Ophthalmology" panel discussion at the 23rd annual Glaucoma 360 meeting at the Palace Hotel in San Francisco on Feb. 2, 2019.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report
2
Spotlight on women's health: Understanding thyroid eye disease
3
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
4
Argenx discontinues phase 3 UplighTED trials of efgartigimod SC in thyroid eye disease
5












































.png)


